Rho kinase inhibitors Y27632 and H1152 augment neurite extension in the presence of cultured Schwann cells

por Fuentes, Erick O, Leemhuis, Jost, Stark, G Björn, Lang, Eva M
Publicado 2008

Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts – the CONFIDENCE...

por Dirks, Petra, Zingler, Vera, Leemhuis, Jost, Berthold, Heike, Hieke-Schulz, Stefanie, Wormser, David, Ziemssen, Tjalf
Publicado 2020

Reelin induces EphB activation

por Bouché, Elisabeth, Romero-Ortega, Mario I, Henkemeyer, Mark, Catchpole, Timothy, Leemhuis, Jost, Frotscher, Michael, May, Petra, Herz, Joachim, Bock, Hans H
Publicado 2013

Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study

por Weber, Martin S., Buttmann, Mathias, Meuth, Sven G., Dirks, Petra, Muros-Le Rouzic, Erwan, Eggebrecht, Julius C., Hieke-Schulz, Stefanie, Leemhuis, Jost, Ziemssen, Tjalf
Publicado 2022